SEMMA THERAPEUTICS, INC.

Profile

Company Names

SEMMA THERAPEUTICS, INC.

Addresses

450 KENDALL STREET, STE 2B, CAMBRIDGE, MA 02142

450 KENDALL STREET, 5TH FLOOR, CAMBRIDGE, MA 02142

Phone Numbers

617-901-4221
857-529-6430

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2014

State Incorporated:

DELAWARE

Total Amount Raised:

$129,278,787.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2017-11-27 
$113,860,712.00 
$119,860,708.00 
$5,999,996.00 
Equity 
1
2015-03-19 
$15,418,075.00 
$25,018,073.00 
$9,599,998.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DANIEL 
 
AUERBACH 
DIRECTOR
EDGEMAKERS, INC.   |  SEMMA THERAPEUTICS, INC.   |  SHOUTI INC.
MITCH 
 
FINER 
DIRECTOR
SEMMA THERAPEUTICS, INC.   |  ABATA THERAPEUTICS, INC.
MITCHELL 
 
FINER 
DIRECTOR
INTRACEL HOLDINGS CORP   |  ADVANTAGENE, INC.   |  ONCORUS, INC.   |  SEMMA THERAPEUTICS, INC.
MARK 
 
FISHMAN 
DIRECTOR
BNA CHICAGO LLC   |  AESIR CREDIT PARTNERS, LP   |  1601 WEST DIVISION LLC   |  AESIR CREDIT OFFSHORE FUND, LTD.   |  SEMMA THERAPEUTICS, INC.   |  BEAM THERAPEUTICS INC.   |  ADITUM BIO FUND 1, L.P.
TODD 
 
FOLEY 
EXECUTIVE OFFICER, DIRECTOR
RHYTHM PHARMACEUTICALS, INC.   |  ZALICUS INC.   |  CELLADON CORP   |  SELEXYS PHARMACEUTICALS CORP   |  PROTEON THERAPEUTICS INC   |  ICONIC THERAPEUTICS INC   |  VALERITAS INC   |  TETHEREX PHARMACEUTICALS CORP   |  CLINICAL INK, INC.   |  SEMMA THERAPEUTICS, INC.   |  RHYTHM METABOLIC, INC.   |  RHYTHM PHARMACEUTICALS, INC.   |  ENTRADA THERAPEUTICS, INC.   |  MOAT BIOTECHNOLOGY CORP   |  CROSSBOW THERAPEUTICS, INC.   |  FIREFLY BIO, INC.   |  AKTIS ONCOLOGY, INC.
STEPHEN 
 
KNIGHT 
DIRECTOR
IRONWOOD PHARMACEUTICALS INC   |  US GENOMICS INC   |  IORA HEALTH, INC.   |  BLUEPRINT MEDICINES CORP   |  PROTEOSTASIS THERAPEUTICS, INC.   |  SEMMA THERAPEUTICS, INC.   |  BEAM THERAPEUTICS INC.   |  SANA BIOTECHNOLOGY, INC.   |  ENSOMA, INC.   |  QUANTUM CIRCUITS, INC.   |  QUARRY GLUE HOLDING CO LLC
ROBERT 
 
MILLMAN 
EXECUTIVE OFFICER, DIRECTOR
COSTIM PHARMACEUTICALS INC.   |  SEMMA THERAPEUTICS, INC.   |  ABCURO, INC.   |  NAYAN THERAPEUTICS, INC.
KEVIN 
 
RAIDY 
DIRECTOR
SEMMA THERAPEUTICS, INC.   |  PLIANT THERAPEUTICS, INC.   |  COWEN HEALTHCARE INVESTMENTS III LP   |  CHI EF III LP   |  ESCIENT PHARMACEUTICALS INC   |  ARO BIOTHERAPEUTICS CO   |  COWEN HEALTHCARE INVESTMENTS IV LP   |  CHI EF IV LP   |  LATIGO BIOTHERAPEUTICS, INC.
WILLIAM 
 
SAHLMAN 
DIRECTOR
IWALK, INC.   |  SEMMA THERAPEUTICS, INC.
BASTIANO 
 
SANNA 
EXECUTIVE OFFICER, DIRECTOR
MAGENTA THERAPEUTICS, INC.   |  SEMMA THERAPEUTICS, INC.
JIM 
 
SCOPA 
DIRECTOR
SEMMA THERAPEUTICS, INC.   |  DICE MOLECULES HOLDINGS, LLC
ELIZABETH 
 
STONER 
EXECUTIVE OFFICER
RADIUS HEALTH, INC.   |  ONCOLOGY INVESTORS OF TEXAS COSTIM, LLC   |  VASCULAR PHARMACEUTICALS, INC.   |  SEMMA THERAPEUTICS, INC.
KINGSLEY 
 
TAFT 
EXECUTIVE OFFICER
SEMMA THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-02-26
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-11-27 
2017-12-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-11-27 
2016-03-31
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-03-19 
2015-04-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-03-19 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#